Bacteria-Induced Group 2 Innate Lymphoid Cells in the Stomach Provide Immune Protection through Induction of IgA.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
14 04 2020
Historique:
received: 19 08 2019
revised: 15 01 2020
accepted: 06 03 2020
pubmed: 3 4 2020
medline: 5 11 2020
entrez: 3 4 2020
Statut: ppublish

Résumé

The intestinal microbiota shapes and directs immune development locally and systemically, but little is known about whether commensal microbes in the stomach can impact their immunological microenvironment. Here, we report that group 2 innate lymphoid cells (ILC2s) were the predominant ILC subset in the stomach and show that their homeostasis and effector functions were regulated by local commensal communities. Microbes elicited interleukin-7 (IL-7) and IL-33 production in the stomach, which in turn triggered the propagation and activation of ILC2. Stomach ILC2s were also rapidly induced following infection with Helicobacter pylori. ILC2-derived IL-5 resulted in the production of IgA, which coated stomach bacteria in both specific pathogen-free (SPF) and H. pylori-infected mice. Our study thus identifies ILC2-dependent IgA response that is regulated by the commensal microbiota, which is implicated in stomach protection by eliminating IgA-coated bacteria including pathogenic H. pylori.

Identifiants

pubmed: 32240600
pii: S1074-7613(20)30090-X
doi: 10.1016/j.immuni.2020.03.002
pii:
doi:

Substances chimiques

Il33 protein, mouse 0
Immunoglobulin A 0
Interleukin-33 0
Interleukin-5 0
Interleukin-7 0
interleukin-7, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

635-649.e4

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Naoko Satoh-Takayama (N)

Laboratory for Intestinal Ecosystem, Center for Integrative Medical Sciences, RIKEN Yokohama, Kanagawa 230-0045, Japan; Immunobiology Laboratory, Graduate School of Medical Life Science, Yokohama City University Yokohama, Kanagawa 230-0045, Japan. Electronic address: naoko.satoh@riken.jp.

Tamotsu Kato (T)

Laboratory for Intestinal Ecosystem, Center for Integrative Medical Sciences, RIKEN Yokohama, Kanagawa 230-0045, Japan; Immunobiology Laboratory, Graduate School of Medical Life Science, Yokohama City University Yokohama, Kanagawa 230-0045, Japan.

Yasutaka Motomura (Y)

Laboratory for Innate Immune Systems, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University Suita, Osaka 565-0871, Japan; Laboratory for Innate Immune Systems, Center for Integrative Medical Sciences, RIKEN Yokohama, Kanagawa 230-0045, Japan.

Tomoko Kageyama (T)

Laboratory for Intestinal Ecosystem, Center for Integrative Medical Sciences, RIKEN Yokohama, Kanagawa 230-0045, Japan.

Naoko Taguchi-Atarashi (N)

Laboratory for Intestinal Ecosystem, Center for Integrative Medical Sciences, RIKEN Yokohama, Kanagawa 230-0045, Japan; Immunobiology Laboratory, Graduate School of Medical Life Science, Yokohama City University Yokohama, Kanagawa 230-0045, Japan.

Ryo Kinoshita-Daitoku (R)

Department of Infection Microbiology, Research Institute for Microbial Diseases, Osaka University Suita, Osaka 565-0871, Japan.

Eisuke Kuroda (E)

Department of Infection Microbiology, Research Institute for Microbial Diseases, Osaka University Suita, Osaka 565-0871, Japan.

James P Di Santo (JP)

Innate Immunity Unit, Institut Pasteur, Paris 75015, France; Institut National de la Santé et de la Recherche Médicale (INSERM), U1223 Paris 75013, France.

Hitomi Mimuro (H)

Department of Infection Microbiology, Research Institute for Microbial Diseases, Osaka University Suita, Osaka 565-0871, Japan.

Kazuyo Moro (K)

Laboratory for Innate Immune Systems, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University Suita, Osaka 565-0871, Japan; Laboratory for Innate Immune Systems, Center for Integrative Medical Sciences, RIKEN Yokohama, Kanagawa 230-0045, Japan.

Hiroshi Ohno (H)

Laboratory for Intestinal Ecosystem, Center for Integrative Medical Sciences, RIKEN Yokohama, Kanagawa 230-0045, Japan; Immunobiology Laboratory, Graduate School of Medical Life Science, Yokohama City University Yokohama, Kanagawa 230-0045, Japan; Intestinal Microbiota Project, Kanagawa Institute of Industrial Science and Technology Ebina, Kanagawa 243-0435, Japan. Electronic address: hiroshi.ohno@riken.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH